- Home
- NKTR vs IDR Comparison
NKTR vs IDR Comparison
Compare NKTR & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- IDR
- Stock Information
- Founded
- NKTR 1990
- IDR 1996
- Country
- NKTR United States
- IDR United States
- Employees
- NKTR N/A
- IDR N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- NKTR Health Care
- IDR Basic Materials
- Exchange
- NKTR Nasdaq
- IDR Nasdaq
- Market Cap
- NKTR 160.4M
- IDR 154.1M
- IPO Year
- NKTR 1994
- IDR N/A
- Fundamental
- Price
- NKTR $0.64
- IDR $18.08
- Analyst Decision
- NKTR Strong Buy
- IDR Strong Buy
- Analyst Count
- NKTR 6
- IDR 1
- Target Price
- NKTR $4.92
- IDR $17.50
- AVG Volume (30 Days)
- NKTR 2.8M
- IDR 334.9K
- Earning Date
- NKTR 05-08-2025
- IDR 05-05-2025
- Dividend Yield
- NKTR N/A
- IDR N/A
- EPS Growth
- NKTR N/A
- IDR 644.44
- EPS
- NKTR N/A
- IDR 0.67
- Revenue
- NKTR $98,427,000.00
- IDR $25,765,373.00
- Revenue This Year
- NKTR N/A
- IDR $9.76
- Revenue Next Year
- NKTR N/A
- IDR N/A
- P/E Ratio
- NKTR N/A
- IDR $26.99
- Revenue Growth
- NKTR 9.21
- IDR 88.66
- 52 Week Low
- NKTR $0.43
- IDR $7.59
- 52 Week High
- NKTR $1.93
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- NKTR 45.85
- IDR 68.96
- Support Level
- NKTR $0.43
- IDR $14.06
- Resistance Level
- NKTR $0.68
- IDR $18.33
- Average True Range (ATR)
- NKTR 0.08
- IDR 1.45
- MACD
- NKTR 0.01
- IDR 0.32
- Stochastic Oscillator
- NKTR 72.41
- IDR 75.19
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.